High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Synopsys Inc (SNPS) reports robust Q2 2026 results, exceeding revenue and EPS guidance, while raising full-year forecasts amid strong market momentum and successful Ansys integration.
Moby summary of Synopsys, Inc.'s Q2 2026 earnings call
Synopsys (NASDAQ:SNPS) reported fiscal second-quarter results above its own guidance and raised its full-year outlook, citing solid execution, demand tied to artificial intelligence chip development and early benefits from its integration of Ansys. President and CEO Sassine Ghazi said Synopsys deli
Before we begin, I would like to remind everyone that during the course of this conference call, Synopsys will discuss forecasts, targets and other forward looking statements regarding the company and its financial results. EDA IP and multiphysics simulation have emerged as essential capabilities in the AI supply chain.
Investing.com -- Synopsys reported stronger-than-expected second-quarter fiscal 2026 results on Wednesday, driven by rising demand for semiconductor design and AI-related engineering solutions.
The headline numbers for Synopsys (SNPS) give insight into how the company performed in the quarter ended April 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Synopsys (SNPS) delivered earnings and revenue surprises of +5.76% and +1.13%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Synopsys raised its annual results forecast on Wednesday, signaling steady demand for its chip design software from companies racing to develop AI chips and infrastructure. Demand tied to AI has been strong as chipmakers and hyperscalers continued investing in more complex semiconductor designs and intelligent systems. The company expects fiscal 2026 revenue between $9.63 billion and $9.71 billion, up from its previous forecast of $9.56 billion to $9.66 billion.
Chip-design software company added Jesse Cohn to its board of directors as part of an agreement with activist investor Elliott Investment Management.
Synopsys handily beat estimates for its fiscal second quarter and with its outlook for the current quarter. But SNPS stock fell.
Chip design software maker Synopsys has reached an agreement with activist investor Elliott Investment Management that will give one board seat to the activist investor's managing partner Jesse Cohn, the company said on Wednesday. Synopsys, which has a market valuation of about $100 billion and counts Tesla and Google parent Alphabet among its customers, has held discussions with Elliott, one of the industry's most powerful activists, for roughly two months. Elliott pushed the company to improve its margins and Synopsys' stock price has climbed roughly 20% since Elliott's involvement became public.
(Bloomberg) -- While software stocks rebound from the artificial intelligence-driven wipeout earlier this year, Salesforce Inc. hasn’t really benefited. But its earnings after the close Wednesday could pull the company’s shares out of their malaise. Most Read from BloombergIran’s Khamenei Says No Going Back for Middle East Rocked by WarSingapore Hands Byju's Founder His First Ever Jail TermPutin Signs Law on Use of Army to Aid Russians Detained AbroadEx-President Biden Sues to Stop DOJ Sharing I
June S&P 500 E-Mini futures (ESM26) are up +0.36%, and June Nasdaq 100 E-Mini futures (NQM26) are up +0.56% this morning as optimism surrounding artificial intelligence and hopes for a U.S.-Iran peace deal boosted sentiment.
Synopsis will report earnings after the close Wednesday. Investors are keen to see how the integration of Ansys is going after the $35 billion acquisition.
The bear case on SNPS is structural. Synopsys (NASDAQ:SNPS) gets lumped in with the AI hardware winners because it sells the software that designs the chips. The narrative is clean. The financial model is something else entirely. Synopsys sits inside a duopoly with Cadence (NASDAQ:CDNS) in electronic design automation, plus a semiconductor IP catalog. It also ... Synopsys Is the ‘Growth Trap’ Your Advisor Won’t Warn You About
June S&P 500 E-Mini futures (ESM26) are up +0.67%, and June Nasdaq 100 E-Mini futures (NQM26) are up +1.03% this morning as investors remained hopeful that the latest U.S. strikes on Iran would not derail talks to end the Middle East conflict.
This week, investors will get their latest sense of how the American consumer is grappling with the wartime inflation surge. Earnings are due from retailers like Costco and Dollar Tree, and the personal-consumption expenditures index for April is scheduled for release.
Broadcom Inc., Applied Materials Inc., GlobalFoundries Inc., Meta Platforms Inc., and Synopsys, Inc. announced on Thursday that they have partnered with the UCLA Samueli School of Engineering to launch a $125 million Semiconductor Hub aimed at accelerating research and workforce...
Applied Materials (NasdaqGS:AMAT) is joining Meta, Broadcom, GlobalFoundries, and Synopsys to fund a new US$125 million semiconductor research hub at UCLA. The hub is focused on next generation chip and AI technologies and is intended to support a more resilient U.S. semiconductor supply chain. This multi company partnership positions Applied Materials at the center of collaborative research across equipment, design, foundry, and end user segments. For you as an investor, this move...
SNPS heads into Q2 earnings results with AI-driven chip demand and Synopsys.ai adoption expected to support revenue growth.
Synopsys has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Five-year partnership aims to support next-generation semiconductor research.
Broadcom and Meta Trigger $125 Million AI Chip Race
Synopsys (SNPS) closed the most recent trading day at $503.98, moving +1.01% from the previous trading session.
Evaluate the expected performance of Synopsys (SNPS) for the quarter ended April 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
The average brokerage recommendation (ABR) for Synopsys (SNPS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
